López-Pascual, E.; Rienda, I.; Perez-Rojas, J.; Rapisarda, A.; Garcia-Llorens, G.; Jover, R.; Castell, J.V.
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways. Int. J. Mol. Sci. 2024, 25, 5203.
https://doi.org/10.3390/ijms25105203
AMA Style
López-Pascual E, Rienda I, Perez-Rojas J, Rapisarda A, Garcia-Llorens G, Jover R, Castell JV.
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways. International Journal of Molecular Sciences. 2024; 25(10):5203.
https://doi.org/10.3390/ijms25105203
Chicago/Turabian Style
López-Pascual, Ernesto, Ivan Rienda, Judith Perez-Rojas, Anna Rapisarda, Guillem Garcia-Llorens, Ramiro Jover, and José V. Castell.
2024. "Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways" International Journal of Molecular Sciences 25, no. 10: 5203.
https://doi.org/10.3390/ijms25105203
APA Style
López-Pascual, E., Rienda, I., Perez-Rojas, J., Rapisarda, A., Garcia-Llorens, G., Jover, R., & Castell, J. V.
(2024). Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways. International Journal of Molecular Sciences, 25(10), 5203.
https://doi.org/10.3390/ijms25105203
